Oxaliplatin Resistance in Colorectal Cancer Enhances TRAIL Sensitivity Via Death Receptor 4 Upregulation and Lipid Raft Localization
J. D. Greenlee, M. Lopez-Cavestany, N. Ortiz-Otero, K. Liu, T. Subramanian, B. Cagir, M. R. King
This study shows oxaliplatin-resistant colorectal cancer cells become more sensitive to TRAIL due to increased DR4 expression, palmitoylation, and lipid raft localization.
bioRxiv · Mar 5, 2021Cancer Biology